How can Acousia Therapeutics’ Kv7.4 activators enhance and preserve natural hearing?

Project specs

Contact

Jonas Dyhrfjeld-Johnsen

Country

Germany

Length

01:00

Summary

Acousia Therapeutics’ Kv7.4 potassium channel activators enhance the sensitivity, tuning and homeostatic resilience of sensory outer hair cells in the cochlea to treat sensorineural hearing loss by enhancing and preserving natural hearing.

Researcher Profile

A quick guide on how to POP, use, and…

Developed by Hygienius, the POPPA is a high-quality single-use system…